These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9519960)

  • 21. Myocardial calcification caused by secondary hyperparathyroidism due to dietary deficiency of calcium and vitamin D.
    Zaidi AN; Ceneviva GD; Phipps LM; Dettorre MD; Mart CR; Thomas NJ
    Pediatr Cardiol; 2005; 26(4):460-3. PubMed ID: 15690240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcimimetics versus vitamin D: what are their relative roles?
    Drüeke TB
    Blood Purif; 2004; 22(1):38-43. PubMed ID: 14732810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a new solid formulation of calcium and vitamin D in institutionalized elderly subjects. A randomized comparative trial versus separate administration of both constituents.
    Sebert JL; Garabedian M; Chauvenet M; Maamer M; Agbomson F; Brazier M
    Rev Rhum Engl Ed; 1995 Apr; 62(4):288-94. PubMed ID: 7606425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium and vitamin D supplements: effects on calcium metabolism in elderly people.
    Chapuy MC; Chapuy P; Meunier PJ
    Am J Clin Nutr; 1987 Aug; 46(2):324-8. PubMed ID: 3497572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dual vitamin D pathways: considerations for adequate supplementation.
    Cronin SC
    Nephrol Nurs J; 2010; 37(1):19-26, 36; quiz 27-8. PubMed ID: 20333900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D and hyperparathyroidism: the Lumleian Lecture 1981.
    Stanbury SW
    J R Coll Physicians Lond; 1981 Oct; 15(4):205-9, 212-7. PubMed ID: 6976436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomised clinical study of alfacalcidol and paricalcitol.
    Hansen D
    Dan Med J; 2012 Feb; 59(2):B4400. PubMed ID: 22293059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
    Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
    Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early assessment of secondary hyperparathyroidism.
    Peregrin T
    J Am Diet Assoc; 2006 Jan; 106(1):22-3. PubMed ID: 16390661
    [No Abstract]   [Full Text] [Related]  

  • 30. [Vitamin D deficiency and supplementation in the elderly. A comparative trial of various modalities of administrating vitamin D2].
    Sebert JL; Fardellone P; Liu S; Ruiz JC; Bellony R; Cohen-Solal M; Perdu V; Defrance D
    Rev Rhum Mal Osteoartic; 1988; 55(9):693-700. PubMed ID: 3055249
    [No Abstract]   [Full Text] [Related]  

  • 31. Follow-up study of biological parameters in elderly institutionalized patients more than one year after discontinuation of calcium-vitamin D supplementation.
    Sebert JL; Fardellone P; Maamer M; Agbomson F; Brazier M; Garabedian M
    Rev Rhum Engl Ed; 1996; 63(7-8):498-501. PubMed ID: 8896064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin D insufficiency as a cause of hyperparathyroidism.
    Oh RC
    Am Fam Physician; 2005 Jan; 71(1):46, 49. PubMed ID: 15663024
    [No Abstract]   [Full Text] [Related]  

  • 33. Vitamin D in Chronic Kidney Disease and Dialysis Patients.
    Jean G; Souberbielle JC; Chazot C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
    Malluche HH; Ritz E
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
    [No Abstract]   [Full Text] [Related]  

  • 35. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary hyperparathyroidism in nutritional osteomalacia.
    Rizvi SN; Vaishinava H
    J Indian Med Assoc; 1975 Apr; 64(8):199-204. PubMed ID: 1080494
    [No Abstract]   [Full Text] [Related]  

  • 37. Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D.
    Maeda SS; Borba VZ; Camargo MB; Silva DM; Borges JL; Bandeira F; Lazaretti-Castro M;
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):411-33. PubMed ID: 25166032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of vitamin D deficient osteomalacia may unmask autonomous hyperparathyroidism.
    Taylor AV; Wise PH
    Postgrad Med J; 1997 Dec; 73(866):813-5. PubMed ID: 9497953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the secondary hyperparathyroidism in vitamin D deficiency rickets. I. Aspects of mineral metabolism.
    Viansel M; Manderlier T; Corvilain J; Vis HL
    Biomedicine; 1974 Sep; 21(9):368-71. PubMed ID: 4457157
    [No Abstract]   [Full Text] [Related]  

  • 40. Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density.
    Adams JS; Kantorovich V; Wu C; Javanbakht M; Hollis BW
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2729-30. PubMed ID: 10443668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.